Zobrazeno 1 - 10
of 16
pro vyhledávání: '"P M, Battezzati"'
Autor:
Surain B. Roberts, Woo Jin Choi, Lawrence Worobetz, Catherine Vincent, Jennifer A. Flemming, Angela Cheung, Karim Qumosani, Mark Swain, Dusanka Grbic, Hin Hin Ko, Kevork M. Peltekian, Lusine Abrahamyan, Monika Saini, Kattleya Tirona, Bishoi Aziz, Ellina Lytvyak, Pietro Invernizzi, Cyriel Y. Ponsioen, Tony Bruns, Nora Cazzagon, Keith Lindor, George N. Dalekos, Nikolaos K. Gatselis, Xavier Verhelst, Annarosa Floreani, Christophe Corpechot, Marlyn J. Mayo, Cynthia Levy, Maria-Carlota Londoño, Pier M. Battezzati, Albert Pares, Frederik Nevens, Adriaan van der Meer, Kris V. Kowdley, Palak J. Trivedi, Ana Lleo, Douglas Thorburn, Marco Carbone, Nazia Selzner, Aliya F. Gulamhusein, Harry LA. Janssen, Aldo J. Montano-Loza, Andrew L. Mason, Gideon M. Hirschfield, Bettina E. Hansen
Publikováno v:
JHEP Reports, Vol 6, Iss 10, Pp 101168- (2024)
Background & Aims: Biochemical response to ursodeoxycholic acid (UDCA) therapy is associated with good prognosis in people living with primary biliary cholangitis (PBC). Biochemical response is typically assessed early in disease and it is not known
Externí odkaz:
https://doaj.org/article/8d1c44ac78ae4a3ebc2eca8571c39ace
Autor:
D. De Giorgio, G. Maggiore, P. M. Battezzati, A. Crosignani, L. Costantino, M. Antelmi, V. Motta, B. Acaia, D. A. Coviello, C. Colombo, VAJRO, PIETRO
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::3d1ed15dac3725f2678dd30f03bfc6e0
http://hdl.handle.net/11386/3103759
http://hdl.handle.net/11386/3103759
Publikováno v:
Alimentary pharmacologytherapeutics. 25(2)
Metabolic bone disease associated with primary biliary cirrhosis (PBC) is inadequately characterized. Renal tubular acidosis (RTA) may lead to bone loss through chronic mobilization of skeletal calcium salts to buffer increased acid load.To evaluate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::43e8a2e75edacba9eec39f65b3b95611
https://pubmed.ncbi.nlm.nih.gov/17439515
https://pubmed.ncbi.nlm.nih.gov/17439515
Autor:
P M, Battezzati, M, Zuin, A, Crosignani, M, Allocca, P, Invernizzi, C, Selmi, E, Villa, M, Podda
Combined medical treatment may provide further benefit to primary biliary cirrhosis (PBC) patients administered ursodeoxycholic acid (UDCA).To evaluate the long-term effects of colchicine and UDCA in symptomatic PBC patients.We extended up to 10 year
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::4e153e68ac6ede2ddbc8db3744c7483d
https://hdl.handle.net/11380/6359
https://hdl.handle.net/11380/6359
Autor:
C, Colombo, P M, Battezzati
Publikováno v:
European journal of gastroenterologyhepatology. 8(8)
Cystic fibrosis is the most common, potentially lethal genetic defect in the Caucasian population. During recent years it has been increasingly associated with a number of hepatic and biliary abnormalities, of which chronic cholestatic liver disease
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2b2ddad0f4c621c251bae135738b8bb9
https://pubmed.ncbi.nlm.nih.gov/8864670
https://pubmed.ncbi.nlm.nih.gov/8864670
Publikováno v:
Hepatology (Baltimore, Md.). 23(6)
Liver disease is increasingly recognized as a major cause of morbidity in cystic fibrosis (CF). Preliminary data suggest that ursodeoxycholic acid (UDCA) may be beneficial for treatment of this manifestation. We performed a double-blind, multicenter
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d23d08d96ade46a778dbe60efbaad489
https://pubmed.ncbi.nlm.nih.gov/8675168
https://pubmed.ncbi.nlm.nih.gov/8675168
Publikováno v:
The Italian journal of gastroenterology. 28(2)
A review is made of the literature regarding the present status of ursodeoxycholic acid in the treatment of primary biliary cirrhosis, focusing on the difficulties encountered in establishing the efficacy of this and any other therapy in the manageme
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1a6a0e9e899ef91a430dc67f024dade1
https://pubmed.ncbi.nlm.nih.gov/8782007
https://pubmed.ncbi.nlm.nih.gov/8782007
Autor:
M, Camisasca, A, Crosignani, P M, Battezzati, W, Albisetti, G, Grandinetti, L, Pietrogrande, A, Biffi, M, Zuin, M, Podda
Publikováno v:
Hepatology (Baltimore, Md.). 20(3)
No satisfactory treatment is available for metabolic bone disease associated with primary biliary cirrhosis. On the basis of the similarities to postmenopausal osteoporosis, the rationale exists for calcitonin to be tested in clinical studies in pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::549f7ec1be78b74d5ab933f4aea6a15f
https://pubmed.ncbi.nlm.nih.gov/8076921
https://pubmed.ncbi.nlm.nih.gov/8076921
Autor:
P M, Battezzati, M, Podda, S, Bruno, M, Zuin, A, Crosignani, M, Camisasca, A, Chiesa, M L, Petroni, A, Russo, P, Gallotti
Publikováno v:
The Italian journal of gastroenterology. 24(9)
To evaluate cost-effectiveness and response predictors of treatment with recombinant interferon alpha-2a in chronic non-A, non-B hepatitis, 263 consecutive patients were enrolled in a multicenter long-term study. A pre-planned analysis aimed at ident
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f07d7a291386959591e0b9569aaa7285
https://pubmed.ncbi.nlm.nih.gov/1362657
https://pubmed.ncbi.nlm.nih.gov/1362657
Publikováno v:
The Italian journal of gastroenterology. 24(1)
Liver-cell dysplasia is a well known histological entity with preneoplastic significance in experimental hepatic carcinogenesis. However, while the association of liver-cell dysplasia with hepatitis B virus can be considered as established, it is sti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4f2ca747bbeb002ab1dbf8098e64413e
https://pubmed.ncbi.nlm.nih.gov/1315175
https://pubmed.ncbi.nlm.nih.gov/1315175